Your browser doesn't support javascript.
loading
Endogenous TLR2 ligand embedded in the catalytic region of human cysteinyl-tRNA synthetase 1.
Cho, Seongmin; Kim, Sang Bum; Lee, Youngjin; Song, Ee Chan; Kim, Uijoo; Kim, Hyeong Yun; Suh, Ji Hun; Goughnour, Peter C; Kim, YounHa; Yoon, Ina; Shin, Na Young; Kim, Doyeun; Kim, Il-Kyu; Kang, Chang-Yuil; Jang, Song Yee; Kim, Myung Hee; Kim, Sunghoon.
Afiliação
  • Cho S; Medicinal Bioconvergence Research Center and College of Pharmacy, Seoul National University, Suwon, South Korea.
  • Kim SB; Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, and College of Pharmacy, Seoul National University, Seoul, South Korea.
  • Lee Y; Medicinal Bioconvergence Research Center and College of Pharmacy, Seoul National University, Suwon, South Korea.
  • Song EC; Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, and College of Pharmacy, Seoul National University, Seoul, South Korea.
  • Kim U; Infection and Immunity Research Laboratory, Metabolic Regulation Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, South Korea.
  • Kim HY; Medicinal Bioconvergence Research Center and College of Pharmacy, Seoul National University, Suwon, South Korea.
  • Suh JH; Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, and College of Pharmacy, Seoul National University, Seoul, South Korea.
  • Goughnour PC; Medicinal Bioconvergence Research Center and College of Pharmacy, Seoul National University, Suwon, South Korea.
  • Kim Y; Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, and College of Pharmacy, Seoul National University, Seoul, South Korea.
  • Yoon I; Medicinal Bioconvergence Research Center and College of Pharmacy, Seoul National University, Suwon, South Korea.
  • Shin NY; Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, and College of Pharmacy, Seoul National University, Seoul, South Korea.
  • Kim D; Medicinal Bioconvergence Research Center and College of Pharmacy, Seoul National University, Suwon, South Korea.
  • Kim IK; Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, and College of Pharmacy, Seoul National University, Seoul, South Korea.
  • Kang CY; Medicinal Bioconvergence Research Center and College of Pharmacy, Seoul National University, Suwon, South Korea.
  • Jang SY; Medicinal Bioconvergence Research Center and College of Pharmacy, Seoul National University, Suwon, South Korea.
  • Kim MH; Medicinal Bioconvergence Research Center and College of Pharmacy, Seoul National University, Suwon, South Korea.
  • Kim S; Medicinal Bioconvergence Research Center and College of Pharmacy, Seoul National University, Suwon, South Korea.
J Immunother Cancer ; 8(1)2020 05.
Article em En | MEDLINE | ID: mdl-32461342
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas Anticâncer / Receptor 2 Toll-Like / Aminoacil-tRNA Sintetases / Imunidade Celular / Imunoterapia / Neoplasias Experimentais Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: J Immunother Cancer Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Coréia do Sul
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas Anticâncer / Receptor 2 Toll-Like / Aminoacil-tRNA Sintetases / Imunidade Celular / Imunoterapia / Neoplasias Experimentais Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: J Immunother Cancer Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Coréia do Sul